But current and former agency staff, as well as medical ethics experts, say recent cuts at the FDA are already making it more ...

Therefore, it is critical to be open and transparent about the process that the U.S. Food and Drug Administration will follow to help make safe and effective COVID-19 vaccines available.

The American Medical Association wants to be sure the U.S. Food and Drug Administration is transparent and “continuously” informing physicians about its review process for a vaccine for the ...

FDA Announces Improved Transparency, Public Disclosure Policies. Aug 05, 2008; ... the background information provided to advisory committee members in advance of a meeting.

House appropriators advanced a bill to fund the FDA for fiscal 2026 on a party-line vote out of a subcommittee Thursday — but ...

Stephen Hahn, commissioner of food and drugs at the U.S. Food and Drug Administration, speaks during a hearing of the Senate Committee on Health, Education, Labor & Pensions in Washington, D.C ...

A tougher, more transparent FDA? Apparently, the agency is trying. Today, FDA is holding its first public meeting on transparency, focusing on ways the agency "can make understandable and useful ...

Tomes left the FDA in 2014 to start her own company, Device Events, which allows users to search the FDA’s medical device adverse events based on keywords — much as you would do a Google search.

The FDA said in March that it had reviewed 99% of the nearly 6.7 million e-cigarette products that have been submitted for premarket authorization, but many of those companies were small players ...

FDA Announces Improved Policies Regarding Transparency, ... the background information provided to advisory committee members in advance of a meeting.

FDA proposes tobacco rules to make manufacturing more consistent and ingredients more transparent ...